Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4286048
Max Phase: Preclinical
Molecular Formula: C37H31BrCl2NO5P
Molecular Weight: 671.54
Molecule Type: Small molecule
Associated Items:
ID: ALA4286048
Max Phase: Preclinical
Molecular Formula: C37H31BrCl2NO5P
Molecular Weight: 671.54
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: O=C(CCCC[P+](c1ccccc1)(c1ccccc1)c1ccccc1)Oc1ccc(-c2ccc(C(=O)C(Cl)Cl)cc2)cc1[N+](=O)[O-].[Br-]
Standard InChI: InChI=1S/C37H31Cl2NO5P.BrH/c38-37(39)36(42)28-21-19-27(20-22-28)29-23-24-34(33(26-29)40(43)44)45-35(41)18-10-11-25-46(30-12-4-1-5-13-30,31-14-6-2-7-15-31)32-16-8-3-9-17-32;/h1-9,12-17,19-24,26,37H,10-11,18,25H2;1H/q+1;/p-1
Standard InChI Key: IXFGKQRMVXJECK-UHFFFAOYSA-M
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 671.54 | Molecular Weight (Monoisotopic): 670.1311 | AlogP: 8.32 | #Rotatable Bonds: 13 |
Polar Surface Area: 86.51 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 0 |
#RO5 Violations: 2 | HBA (Lipinski): 6 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: | CX Basic pKa: | CX LogP: 9.31 | CX LogD: 9.31 |
Aromatic Rings: 5 | Heavy Atoms: 46 | QED Weighted: 0.02 | Np Likeness Score: -0.24 |
1. Xu B, Yu Z, Xiang S, Li Y, Zhang SL, He Y.. (2018) Rational design of mitochondria-targeted pyruvate dehydrogenase kinase 1 inhibitors with improved selectivity and antiproliferative activity., 155 [PMID:29890389] [10.1016/j.ejmech.2018.06.012] |
Source(1):